Johnson Matthey PLC (LON:JMAT - Get Free Report) hit a new 52-week high during mid-day trading on Wednesday . The company traded as high as GBX 1,873 ($25.46) and last traded at GBX 1,852.15 ($25.17), with a volume of 543474 shares traded. The stock had previously closed at GBX 1,852 ($25.17).
Johnson Matthey Stock Up 1.2%
The firm has a market cap of £3.14 billion, a price-to-earnings ratio of 31.86, a price-to-earnings-growth ratio of 49,242.50 and a beta of 0.95. The stock's 50 day moving average is GBX 1,622.02 and its 200 day moving average is GBX 1,447.02. The company has a quick ratio of 0.76, a current ratio of 1.45 and a debt-to-equity ratio of 62.73.
Johnson Matthey (LON:JMAT - Get Free Report) last announced its earnings results on Thursday, May 22nd. The company reported GBX 149.20 ($2.03) earnings per share (EPS) for the quarter. Johnson Matthey had a return on equity of 4.49% and a net margin of 0.84%. Analysts forecast that Johnson Matthey PLC will post 173.4112903 EPS for the current year.
Insider Activity at Johnson Matthey
In related news, insider Liam Condon purchased 30 shares of the stock in a transaction dated Wednesday, April 16th. The shares were acquired at an average cost of GBX 1,200 ($16.31) per share, for a total transaction of £360 ($489.26). In the last 90 days, insiders have acquired 62 shares of company stock worth $84,978. Insiders own 0.61% of the company's stock.
About Johnson Matthey
(
Get Free Report)
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers' products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet's natural resources.
Read More
Before you consider Johnson Matthey, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Johnson Matthey wasn't on the list.
While Johnson Matthey currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
